Reversal of multidrug resistance.
Bates
S E
SE
Medicine Branch, National Cancer Institute, Bethesda, MD 20892.
Zhan
Z
Z
Dickstein
B
B
Lee
J S
JS
Scala
S
S
Fojo
A T
AT
Paull
K
K
Wilson
W
W
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors / Q000235:genetics; D000970:Antineoplastic Agents / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D002986:Clinical Trials as Topic; D018432:Drug Resistance, Multiple / Q000235:genetics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000633:toxicity; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology; D014750:Vincristine / Q000633:toxicity
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D014750:Vincristine; D014700:Verapamil; D017239:Paclitaxel